查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392019

红色生物技术市场：按产品类型、按应用、按最终用户、按地区

Red Biotechnology Market, By Product Type, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

Red Biotechnology的全球市场规模预计将从2023年的7,428亿美元增至2030年的1,5,132.2亿美元，预测期内复合年增长率为10.7%。

报告范围 报告详情
基准年 2022年 2023年市场规模 7428亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 10.70% 2030年市场规模预测 1,513,220 百万美元
图 1. Red Biotechnology全球市场占有率(%)，依地区划分，2023 年
红色生物科技市场-IMG1

红色生物技术，也称为医疗生物技术，是生物技术的子部门，专门从事医疗医疗应用。利用生物技术开发新药、治疗方法和医疗技术来治疗和预防疾病。此外，红色生物技术也被用来开发诊断工具，例如可用于早期发现疾病的基因测试。红色生物技术也用于干细胞研究，有可能彻底改变从癌症到脊髓损伤等多种疾病和病症的治疗。此外，红色生物技术在新药发现和开发中也扮演着重要角色。这包括利用基因工程创造新的治疗方法以及根据个人的基因谱开发个人化医疗。红色生物技术用于基因治疗，这是一种利用基因来治疗或预防疾病的技术。这包括替换有缺陷的基因或将新基因引入体内以对抗疾病。

市场动态：

全球红色生物技术市场的成长是由高龄化、慢性病发病率增加以及流行病导致的全球医疗保健需求增加等多种因素所推动的。基因组学、个人化医疗和基因治疗的进步也是市场成长的关键驱动力。政府投资、监管支援和私营部门日益增长的兴趣正在促进寻求开发创新治疗方法和治疗方法的全球红色生物技术的成长。然而，与生技药品药物开发相关的高成本预计将抑制市场成长。

本研究的主要特点

  • 该研究报告对全球红色生物技术市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球红色生物技术市场的主要企业。
  • 该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
  • 红色生物技术全球市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球红色生物技术市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 慢性病盛行率增加
    • 生技药品的价格压力
    • 生物技术在农业的应用
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球红色生物技术市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球红色生物技术市场，依产品类型，2018-2030

  • 介绍
  • 生物製药
  • 生物相似药
  • 基因治疗
  • 人体组织工程
  • 细胞疗法

第六章全球红色生物技术市场，依应用分类，2018-2030

  • 介绍
  • 药物研发发现与开发
  • 动物生物技术
  • 环境生物技术
  • 医学生物技术
  • 工业生物技术
  • 农业生物技术
  • 其他的

第七章 全球红色生物技术市场，依最终用户划分，2018-2030 年

  • 介绍
  • 製药和生物製药公司
  • 研究机构
  • 生技产业
  • 医院和诊断中心
  • 学术机构

第八章全球红色生物技术市场，按地区，2018-2030

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 东南亚国协
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章竞争形势

  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Biogen
  • Pfizer Inc.
  • Novartis AG
  • F.Hoffmann-La Roche
  • Johnson & Johnson Services, Inc.
  • Sanofi
  • Merck & Co. Inc.
  • AbbVie Inc.
  • GSK plc.
  • AstraZeneca
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim International GmbH
  • Astellas Pharma Inc.

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6416

Global Red Biotechnology Market size is expected to reach US$ 1,513.22 Bn by 2030, from US$ 742.80 Bn in 2023, exhibiting a CAGR of 10.7% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 742.80 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 10.70% 2030 Value Projection: US$ 1,513.22 Bn
Figure 1. Global Red Biotechnology Market Share (%), By Region, 2023
Red Biotechnology Market - IMG1

Red biotechnology, also known as medical biotechnology, is a subsector of biotechnology that focuses on medical and healthcare applications. It involves the use of biotechnology techniques to develop new drugs, therapies, and medical technologies for the treatment and prevention of diseases. Moreover, Red biotechnology is used in the development of diagnostic tools, such as genetic tests, that can be used to detect diseases at an early stage. Red biotechnology is also used in stem cell research, which has the potential to revolutionize the treatment of a wide range of diseases and conditions, from cancer to spinal cord injuries. Furthermore, Red biotechnology plays a crucial role in the discovery and development of new drugs. This includes the use of genetic engineering to create novel therapies, as well as the development of personalized medicine based on an individual's genetic profile. Red biotechnology is used in gene therapy, a technique that uses genes to treat or prevent disease. This can involve replacing a faulty gene, or introducing a new gene into the body to help fight disease.

Market Dynamics:

Global red biotechnology market growth is driven by several factors like increasing global healthcare needs due to aging populations, rising chronic diseases, and pandemics. Advances in genomics, personalized medicine, and gene therapies are also key drivers for the market growth. Government investments, regulatory support, and growing private sector interest contribute to the growth of global red biotechnology that aims to develop innovative medical treatments and therapies. However, high costs associated with biologics drug development is expected to restrain the market growth.

Key features of the study:

  • This report provides in-depth analysis of the global red biotechnology market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global red biotechnology market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Amgen Inc., Gilead Sciences, Inc., Biogen, Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Johnson & Johnson Services, Inc., Sanofi, Merck & Co. Inc., AbbVie Inc., GSK plc., AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Bayer AG, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH and Astellas Pharma Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global red biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global red biotechnology market

Detailed Segmentation:

  • By Product Type
    • Biopharmaceuticals
    • Biosimilars
    • Gene Therapy
    • Tissue Engineering
    • Cell Therapy
  • By Application
    • Drug Discovery & Development
    • Animal Biotechnology
    • Environmental Biotechnology
    • Medical Biotechnology
    • Industrial Biotechnology
    • Agricultural Biotechnology
    • Others
  • By End User
    • Pharmaceutical & Biopharmaceutical Companies
    • Research Institutes
    • Biotechnology Industry
    • Hospitals & Diagnostic Centers
    • Academic Institutions
  • Top companies in Global Red Biotechnology Market
    • Amgen Inc.
    • Gilead Sciences, Inc.
    • Biogen
    • Pfizer Inc.
    • Novartis AG,
    • F.Hoffmann-La Roche
    • Johnson & Johnson Services, Inc.
    • Sanofi
    • Merck & Co. Inc.
    • AbbVie Inc.
    • GSK plc.
    • AstraZeneca
    • Eli Lilly and Company
    • Novo Nordisk A/S
    • Bayer AG
    • Bristol-Myers Squibb Company
    • Teva Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
    • Boehringer Ingelheim International GmbH
    • Astellas Pharma Inc

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet , By End User
    • Market Snippet , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of chronic diseases
    • Pricing pressures on biologics
    • Biotech applications in agriculture
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Red Biotechnology Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Red Biotechnology Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Biopharmaceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Biosimilars
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Gene Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Red Biotechnology Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Drug Discovery & Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Animal Biotechnology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Environmental Biotechnology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Medical Biotechnology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Industrial Biotechnology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Agricultural Biotechnology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Red Biotechnology Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Pharmaceutical & Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Biotechnology Industry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Hospitals & Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Academic Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Red Biotechnology Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Gilead Sciences, Inc.
  • Biogen
  • Pfizer Inc.
  • Novartis AG
  • F.Hoffmann-La Roche
  • Johnson & Johnson Services, Inc.
  • Sanofi
  • Merck & Co. Inc.
  • AbbVie Inc.
  • GSK plc.
  • AstraZeneca
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim International GmbH
  • Astellas Pharma Inc.
  • Analyst Views

10. Section

  • Research Methodology
  • About us